UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

Form 8-K

 

Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 29, 2008

 


 

CardioNet, Inc.
(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of incorporation)

 

001-33993
(Commission File Number)

 

33-0604557
(I.R.S. Employer
Identification No.)

 

 

 

 

 

1010 Second Avenue
San Diego, California
(Address of principal executive offices)

 

92101
(Zip Code)

 

Registrant’s telephone number, including area code:  (619) 243-7500

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o         Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 2.02                Results of Operations and Financial Condition.

 

On April 29, 2008, CardioNet, Inc. announced unaudited financial results for the quarter ended March 31, 2008.  A copy of the press release is included herewith as Exhibit 99.1.

 

Item 9.01                Financial Statements and Exhibits.

 

(d)               Exhibits.

 

99.1         Press release of CardioNet, Inc. dated April 29, 2008.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

CARDIONET, INC.

 

 

 

 

Dated:  April 29, 2008

By:

   /s/ Martin P. Galvan

 

Name:     Martin P. Galvan

 

Title: Chief Financial Officer

 

3



 

INDEX TO EXHIBITS

 

Exhibit
Number

 

Description

99.1

 

Press release of CardioNet, Inc. dated April 29, 2008.

 

4


HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more HeartBeam Charts.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more HeartBeam Charts.